Equity Overview
Price & Market Data
Price: $0.304
Daily Change: -$0.016 / 5.26%
Range: $0.29 - $0.34
Market Cap: $5,850,627
Volume: 2,168,659
Performance Metrics
1 Week: -31.32%
1 Month: -33.90%
3 Months: -86.29%
6 Months: -87.62%
1 Year: -93.60%
YTD: -81.93%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.